+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Surface Markers Market by Product Type (Complementary Reagents, Lectins, Monoclonal Antibodies), Technology (Enzyme Linked Immunosorbent Assay, Flow Cytometry, Immunocytochemistry), Application, End User - Global Forecast 2025-2030- Product Image
Cell Surface Markers Market by Product Type (Complementary Reagents, Lectins, Monoclonal Antibodies), Technology (Enzyme Linked Immunosorbent Assay, Flow Cytometry, Immunocytochemistry), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Cell Surface Markers Market by Product Type (Complementary Reagents, Lectins, Monoclonal Antibodies), Technology (Enzyme Linked Immunosorbent Assay, Flow Cytometry, Immunocytochemistry), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010769
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cell surface markers market is entering a transformative phase as advances in detection, analytics, and regulatory frameworks reshape how organizations in life sciences, diagnostics, and therapeutics leverage these critical molecular tools. Senior decision-makers must carefully evaluate technological, segmentation, and trade factors influencing evolving strategies for growth and risk management.

Market Snapshot: Cell Surface Markers Market Report

The cell surface markers market grew from USD 858.27 million in 2024 to USD 939.88 million in 2025. Demonstrating a CAGR of 9.34%, the market is projected to reach USD 1.46 billion by 2030. This growth is fueled by continuous innovation in multiplexed detection platforms, strong adoption across diagnostics and research applications, and concerted efforts to address supply chain vulnerabilities through diversification. Heightened demand for targeted immunotherapies and precision medicine further drives investment, even in the face of shifting trade policies.

Scope & Segmentation

This research delivers granular coverage of the cell surface markers domain, segmenting the market by technology, product type, application, end user, and key region to support precise benchmarking and opportunity identification.

  • Product Types:
    • Complementary reagents
    • Lectins
    • Monoclonal antibodies: IgA, IgG, IgM
    • Polyclonal antibodies: goat, mouse, rabbit
  • Technologies:
    • Enzyme linked immunosorbent assay
    • Flow cytometry: conventional, imaging, mass cytometry
    • Immunocytochemistry
    • Immunohistochemistry
  • Applications:
    • Diagnostics: cardiovascular, infectious disease, oncology
    • Research: cancer, immunology, stem cell studies
    • Therapeutics: autoimmune, cancer
  • End Users:
    • Academic research institutes
    • Contract research organizations
    • Hospitals and diagnostic laboratories
    • Pharmaceutical and biotechnology companies
  • Regions Covered:
    • Americas: United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan

This report also covers key competitors, including Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Danaher Corporation, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Abcam plc, PerkinElmer, Inc., Agilent Technologies, Inc., and Sartorius AG.

Key Takeaways for Decision-Makers

  • Technological advances are expanding the utility of cell surface markers from basic research to real-world clinical diagnostics, enabling deep phenotypic profiling and supporting personalized medicine initiatives.
  • Integration of machine learning and artificial intelligence tools is rapidly increasing automation of data analysis and discovery, improving accuracy and accelerating research and clinical decision processes.
  • Supply chain agility is increasingly critical, with recent tariffs driving companies to reassess sourcing and shift toward diversified or nearshore vendor models for greater resilience.
  • Segment differentiation—such as tailored monoclonal antibody development and growth in polyclonal formats—aligns product portfolios with emerging applications in immunology, oncology, and cell therapy.
  • Regional investment varies widely, with the Americas offering robust infrastructure, EMEA balancing standardization with access initiatives, and Asia-Pacific accelerating through strong public funding and local manufacturing advances.
  • Competitive strategies now emphasize technology alliances, sustainability commitments, and end-to-end solutions, positioning leading companies for both innovation and scalability.

Tariff Impact on Market Dynamics

The introduction of new US tariffs in 2025 has generated cost pressures across laboratory and diagnostic procurement, triggering a strategic focus on supply chain adaptation. Domestic manufacturing gains, nearshoring, and diversified sourcing are mitigating disruptions, while regional and cross-border collaborations help maintain research momentum in the face of trade-related hurdles.

Methodology & Data Sources

This analysis follows a rigorous approach, combining primary interviews with industry executives, reagent developers, and laboratory directors with exhaustive secondary research from peer-reviewed literature, patent filings, and regulatory documentation. Insights were validated through expert panels and independent cross-review to ensure objectivity and consistency.

Why This Report Matters

  • Gain clarity on evolving opportunities and challenges in the cell surface markers market, supporting informed strategy development.
  • Benchmark against regional dynamics and technology adoption to guide investment or operational decisions.
  • Act confidently with insights underpinned by robust methodology and cross-validated data points.

Conclusion

The cell surface markers market is poised for sustained growth, shaped by technology innovation, regulatory shifts, and adaptive business strategies. Senior leaders will benefit from charting a course that embraces analytical advancement, supply chain flexibility, and focused regional partnerships.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of single-cell RNA sequencing and surface marker profiling for high-resolution immune cell phenotyping
5.2. Adoption of mass cytometry with metal-tagged antibodies for comprehensive surface marker analysis in drug discovery
5.3. Advancements in CAR-T engineering using novel tumor-associated antigen surface markers for solid tumor targeting
5.4. Implementation of AI-driven image cytometry for automated quantification of cell surface marker expression patterns
5.5. Development of bispecific antibody platforms targeting dual cell surface antigens to enhance therapeutic specificity
5.6. Commercialization of microfluidic-based immunophenotyping assays enabling rapid on-chip cell surface marker detection
5.7. Emergence of multiplex flow cytometry panels for simultaneous detection of rare immune cell subsets in clinical trials
5.8. Regulatory approval trends influencing the adoption of standardized surface marker panels in precision oncology diagnostics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell Surface Markers Market, by Product Type
8.1. Introduction
8.2. Complementary Reagents
8.3. Lectins
8.4. Monoclonal Antibodies
8.4.1. IgA
8.4.2. IgG
8.4.3. IgM
8.5. Polyclonal Antibodies
8.5.1. Goat
8.5.2. Mouse
8.5.3. Rabbit
9. Cell Surface Markers Market, by Technology
9.1. Introduction
9.2. Enzyme Linked Immunosorbent Assay
9.3. Flow Cytometry
9.3.1. Conventional Flow Cytometry
9.3.2. Imaging Flow Cytometry
9.3.3. Mass Cytometry
9.4. Immunocytochemistry
9.5. Immunohistochemistry
10. Cell Surface Markers Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Cardiovascular Diagnostics
10.2.2. Infectious Disease Diagnostics
10.2.3. Oncology Diagnostics
10.3. Research
10.3.1. Cancer Research
10.3.2. Immunology Research
10.3.3. Stem Cell Research
10.4. Therapeutics
10.4.1. Autoimmune Disease Therapeutics
10.4.2. Cancer Therapeutics
11. Cell Surface Markers Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Contract Research Organizations
11.4. Hospitals And Diagnostic Laboratories
11.5. Pharmaceutical And Biotechnology Companies
12. Americas Cell Surface Markers Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cell Surface Markers Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cell Surface Markers Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Merck KGaA
15.3.3. Becton, Dickinson and Company
15.3.4. Danaher Corporation
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Bio-Techne Corporation
15.3.7. Abcam plc
15.3.8. PerkinElmer, Inc.
15.3.9. Agilent Technologies, Inc.
15.3.10. Sartorius AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CELL SURFACE MARKERS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CELL SURFACE MARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CELL SURFACE MARKERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CELL SURFACE MARKERS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CELL SURFACE MARKERS MARKET: RESEARCHAI
FIGURE 24. CELL SURFACE MARKERS MARKET: RESEARCHSTATISTICS
FIGURE 25. CELL SURFACE MARKERS MARKET: RESEARCHCONTACTS
FIGURE 26. CELL SURFACE MARKERS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CELL SURFACE MARKERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL SURFACE MARKERS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CELL SURFACE MARKERS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY COMPLEMENTARY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY COMPLEMENTARY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY LECTINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY LECTINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IGA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IGA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IGG, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IGG, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IGM, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IGM, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY GOAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY GOAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MOUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MOUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RABBIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RABBIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMAGING FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMAGING FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOCYTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOCYTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOLOGY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOLOGY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY AUTOIMMUNE DISEASE THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY AUTOIMMUNE DISEASE THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CANCER THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CANCER THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 137. CANADA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. CANADA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. CANADA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 140. CANADA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 141. CANADA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 142. CANADA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 143. CANADA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 144. CANADA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 145. CANADA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 146. CANADA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 147. CANADA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. CANADA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. CANADA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 150. CANADA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 151. CANADA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 152. CANADA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 153. CANADA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 154. CANADA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 155. CANADA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 160. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 161. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 162. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 163. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 166. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 167. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 172. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 173. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 262. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 263. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 264. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 265. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 268. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 269. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 274. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 275. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 276. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 277. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 282. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 283. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 284. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 285. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 286. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 287. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 288. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 289. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 292. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 293. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 294. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 295. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 296. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 297. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. ITALY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. ITALY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. ITALY CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 322. ITALY CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 323. ITALY CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 324. ITALY CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 325. ITALY CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 326. ITALY CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 327. ITALY CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 328. ITALY CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 329. ITALY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 330. ITALY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 331. ITALY CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MIL

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Abcam plc
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Sartorius AG

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 939.88 Million
Forecasted Market Value ( USD ) by 2030 $ 1460 Million
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Cell Surface Markers Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cell Surface Markers Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Cell Surface Markers - Global Strategic Business Report - Product Image

Cell Surface Markers - Global Strategic Business Report

  • Report
  • 683 Pages
  • Global
From
Cell Surface Marker Detection Market Report 2025 - Product Image

Cell Surface Marker Detection Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Global Cell Surface Markers Detection - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Cell Surface Markers Detection - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 114 Pages
  • Global
From
Cell Surface Markers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cell Surface Markers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 184 Pages
  • Global
From

About the Cell Surface Marker Market

Cell surface markers are a type of biomarker used to identify and characterize cells. They are proteins found on the surface of cells that can be used to distinguish between different types of cells, such as healthy and diseased cells. Cell surface markers can be used to diagnose diseases, monitor disease progression, and evaluate the effectiveness of treatments. They can also be used to study the development and function of cells in the body. Cell surface markers are used in a variety of research and clinical applications, including cancer diagnostics, immunology, stem cell research, and drug development. Companies in the cell surface marker market include Bio-Rad Laboratories, Merck KGaA, Thermo Fisher Scientific, Becton Dickinson, and Agilent Technologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.